Together, inhibition of miR‐21 may up‐regulate SMAD7 and improve both cardiac mesenchymal fibrosis and cardiac perivascular fibrosis, thereby promoting myocardial function in T1DM. The gene discussed is SMAD7; the disease is type 1 diabetes mellitus.